OSAS (Obstructive Sleep Apneas Syndrome) Completed Phase 3 Trials for Pitolisant (DB11642)

Also known as: Obstructive Sleep Apnea (OSAS) / Sleep Apnea, Obstructive / Apnea, Obstructive Sleep / Obstructive Sleep Apnea / Obstructive Sleep Apnea (OSA) / Obstrutive Sleep Apnea / Sleep Obstructive Apnea / Sleep Apnea - Obstructive / Sleep Apnea, Obstructives / Sleep Apnea Obstructive (OSA) / OSA - Obstructive Sleep Apnea / Obstructive Sleep Apnea (SAOS) / Sleep Apnea Syndrome (OSAS) / OSA / OSAS / Obstructive Sleep Apnea Syndromes / Obstructive Sleep Apnea Syndrome and / Sleep Apnea Syndromes, Obstructive / Obstructive Sleep-Apnea Syndrome / Obstructive Sleep Apnoea Syndrome / Syndrome, Obstructive Sleep Apnea / Obstructive Sleep Apnea Syndrome (OSAS) / Obstructive Sleep Apnea Syndrome / Obstructive sleep apnea hypopnea / Sleep apnea syndrome / Sleep Apnea Syndromes / Sleep apnoea syndromes / Sleep apnea / Sleep apnoea syndrome / Apnea syndrome / Apnoea syndrome / Sleep apnoeas / Sleep apnoea

IndicationStatusPhase
DBCOND0039984 (OSAS (Obstructive Sleep Apneas Syndrome))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01071876BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDSTreatment
NCT01072968BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.Treatment